Evidence map›Paper›PMID 41663518›Full record

ArticleScientific reports2026

Green synthesis of Ag/ZnO nanocomposites from Phyllanthus emblica seed for multifunctional wound healing applications.

Gunasekaran Vidhyadevi, S R Suseem

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gunasekaran VidhyadeviDepartment of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632 014, Tamil Nadu, India.
S R SuseemDepartment of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632 014, Tamil Nadu, India. srsuseem@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents an efficient and eco-friendly approach for synthesizing ZnO and SZ (Ag/ZnO NPs) nanocomposites using PE (Phyllanthus emblica) seed extract as a reducing agent. UV-vis, XRD, FESEM, EDX and elemental analysis, FT-IR, and AFM were used to characterize zinc oxide and SZ nanocomposites. PE seed extract was used to synthesize zinc oxide and SZ nanocomposites, which had an average particle size of 31.19 and 50.15 nm. Then the antibacterial activity was assessed against Salinivibrio proteolyticus, Bacillus subtilis, and Staphylococcus epidermidis using the agar well diffusion technique. Maximum inhibition zones were observed for SZ nanocomposites (14 mm, 16 mm, and 13 mm), demonstrating their antibacterial activity. Furthermore, the MTT-assay were used to assess the cytotoxicity of ZnO and SZ nanocomposites in NIH-3T3 fibroblast cell lines. The study revealed that ZnO and varying concentrations of SZ NCs (0.5%, 1%, 1.5%, and 2%) showed different in vitro cell survival rates. When treated with SZ nanocomposites at concentrations of 50-250 µg/mL for 24 h, the corresponding survival rates were 189.05 µg/mL to 57.83 µg/mL, respectively. Compared to other weight percentages, the 1.5% SZ NCs demonstrate significant antibacterial and cytotoxic activities. Furthermore, following in vitro studies of antioxidant, anti-inflammatory, and wound-healing assays of 1.5% SZ nanocomposites showed significant efficacy. These findings suggest that the nanocomposites are promising candidates for the treatment of antibacterial and wound-healing therapies.

Indexed as

NanocompositesPhyllanthus emblicaSeedsSilverWound HealingZinc OxideAnimalsAnti-Bacterial AgentsCell SurvivalGreen Chemistry TechnologyMiceMicrobial Sensitivity TestsNIH 3T3 CellsPlant ExtractsStaphylococcus epidermidisAnti-Bacterial AgentsPlant ExtractsSilverZinc OxideCytotoxicityNanocompositesNIH-3T3 cell linePhyllanthus emblicaWound healing assay

Identifiers

PMID41663518
PMCPMC12957500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.